8-K/AThe WireRoutine
Company Update
Filed Jan 24, 2018 · 8y ago · Accession 0001104659-18-003817
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- 8-K/A
- Filing date
- Jan 24, 2018
- Report date
- Nov 17, 2017
- Document
- a18-3571_18ka.htm
- Size
- 1.1 MB